Skip to content

Exablate Model 4000 System

by Insightec

PMA P150038

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P150038↗

FDA record

Trust

Unverified

Source FDA PMA, synced 6 Oct 2026.

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP150038 Date11 Jul 2016ApprovedStatusActive

Official records

From the FDA record

FDA PMA P150038

Received by the FDA
21 Oct 2015
FDA decision
11 Jul 2016
FDA review time
264 days from receipt to decision
Docket number
16M-2183
Approval order statement, verbatim
Approval for the ExAblate Model 4000 Type 1.0 System (ExAblate Neuro). This device is indicated for use in the unilateral Thalamotomy treatment of idiopathic Essential Tremor patients with medication-refractory tremor. Patients must be at least age 22. The designated area in the brain responsible for the movement disorder symptoms (ventralis intermedius) must be identified and accessible for targeted thermal ablation by the ExAblate device.

From the FDA PMA record P150038 (openFDA), as read on 6 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade name
Exablate
Generic name
MR-guided focused ultrasound system
PMA number
FDA product code
POH
Device class
Class III
Advisory committee
Neurology
FDA decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Exablate Model 4000 System is an MR-guided focused ultrasound system indicated for use in the unilateral thalamotomy treatment of idiopathic essential tremor patients with medication-refractory tremor. It targets the ventralis intermedius nucleus in the brain for thermal ablation under MRI guidance.

This system is supplied as a non-sterile, reusable device intended for use in a clinical setting by trained professionals. It requires MRI compatibility for operation and is authorized under FDA PMA (P150038) for the specified neurological indication.

Devices cleared under P150038

4 devices · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under P150038
UDI-DISize and differences
7290019402558 4000 Type 1.1
INSIGHTEC LTD
SYS004000-CA / 4000 Type 1.107290019402558 —On the market
Exablate Neuro Treatment Accessories Kit Exablate 4000
INSIGHTEC LTD
SET004307-ROW / Exablate 400007290019402565 —On the market
HEADFRAME PFK TYPE 1.0 FDA/ROW INTEGRA (FMI)
INSIGHTEC LTD
SET400168-AD / SET400168-AD PFK TYPE 1.0 FDA/ROW INTEGRA (FMI)07290019402442 —On the market
HEADFRAME PFK TYPE 1.1 FDA/ROW INTEGRA (FMI)
INSIGHTEC LTD
SET400168-AE / SET400168-AE PFK TYPE 1.1 FDA/ROW INTEGRA (FMI)07290019402466 —On the market

Other devices from Insightec